Medina Padilla, Miguel,Domínguez Correa, Juan Manuel,De Cristobal Blanco, Javier,Fuertes Huerta, Ana,Sánchez-Quesada, Jorge,López Ogalla, Javier,Herrero Santos, Susana,Pérez De La Cruz Moreno, María Á
申请号：
HRP20170964
公开号：
HRP20170964T1
申请日:
2017.06.26
申请国别(地区):
HR
年份:
2017
代理人:
摘要：
The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.
